|
XLO Xilio Therapeutics Inc 1840233 |
| Balance Sheet |
|
Current Assets
|
$154,207,000.00 |
|
Assets
|
$163,487,000.00 |
|
Current Liabilities
|
$42,960,000.00 |
|
Liabilities
|
$90,942,000.00 |
|
Equity
|
$72,545,000.00 |
|
Shares Out
|
5782536.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-22,343,000.00 |
|
Investing Cash Flow
|
$-556,000.00 |
| Market Analysis |
Market Cap
|
$52,505,426.88 |
|
Price
|
$9.11 |
|
BVPS
|
12.55 |
|
PB
|
0.72 |
|
EPS
|
-0.58 |
|
PS
|
1.05 |
|
FCF
|
$-22,899,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:39 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view XLO documents filed with the SEC.
XLO Filings
Clear
